🕵️ CASI Pharmaceuticals, Inc. ($CASIF)
SEC insider & ownership activity, last 12 months · CIK 1962738 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Wei-Wu HE, PH.D. added 53.0% → 58.8%; James Huang added 19.9% → 22.5%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Wei-Wu HE, PH.D. | 58.8% | 13D | May 18, 2026 | filing ↗ | |
| Emerging Technology Partners, LLC | 52.0% | 13D | May 18, 2026 | filing ↗ | |
| ETP Global III Fund L.P. | 49.3% | 13D | May 18, 2026 | filing ↗ | |
| ETP Global Fund III L.P. | 32.7% | 13D | Feb 9, 2026 | filing ↗ | |
| James Huang | 22.5% | 13D | Dec 16, 2025 | filing ↗ | |
| Panacea Venture Healthcare Fund II GP Company, Ltd. | 22.0% | 13D | Dec 16, 2025 | filing ↗ | |
| Panacea Innovation Limited | 22.0% | 13D | Dec 16, 2025 | filing ↗ | |
| Panacea Venture Healthcare Fund II, L.P. | 22.0% | 13D | Dec 16, 2025 | filing ↗ | |
| Chen Zhenfeng | 11.0% | 13G | Nov 26, 2025 | filing ↗ | |
| Venrock Healthcare Capital Partners III, L.P. | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Management III, LLC | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Management EG, LLC | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Nimish Shah | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Bong Y. Koh | 9.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Foresite Capital Fund VI, L.P. | 5.1% | 13G | Aug 12, 2025 | filing ↗ | |
| Foresite Capital Management VI, LLC | 5.1% | 13G | Aug 12, 2025 | filing ↗ | |
| Beijing Hexie Kangjian Investment Center (LIMITED PARTNERSHIP) | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Beijing Hexie Tiancheng Investment Management Center (LIMITED PARTNERSHIP) | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| HE XIE AI QI Investment Management (BEIJING) Co., Ltd. | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Xizang Hexie Enterprise Management Co., Ltd. | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Zhuhai Hexie Zhiyuan Management Consulting Co., Ltd. | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Jianguang Li | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Dongliang Lin | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Jingbo Wang | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Kuiguang Niu | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Sparkle BYTE Ltd | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| SNOW MOON Ltd | 5.0% | 13D | Sep 30, 2025 | filing ↗ | |
| Tianjin Jingran Management Center (LIMITED PARTNERSHIP) | 5.0% | 13D | Sep 30, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.